2015 - Herzenberg Lectureship Award
Dr. C. Garrison Fathman, Professor of Medicine and Chief of the Division of Immunology and Rheumatology at Stanford University School of Medicine, also serves as Past Chairman of the Federation of Clinical Immunology Societies (FOCIS) and Director of the Center for Clinical Immunology at Stanford (CCIS).
Dr. Fathman’s contributions in translational medicine in the areas of cellular and molecular immunology, as well as adoptive cellular gene therapy, have brought him international recognition. In particular, he is acclaimed for his establishment and exploitation of the technologies of antigen-specific T-cell cloning and adoptive cellular gene therapy, accomplishments that have facilitated a remarkable series of subsequent advances in understanding conventional immune response and treating autoimmune diseases.
As Founder and Past Chairman of FOCIS, Dr. Fathman led an extremely successful international effort to acknowledge and develop the field of clinical immunology. As Director of the CCIS, the Stanford-based FOCIS Center of Excellence, Dr. Fathman has initiated multi-disciplinary studies to generate novel approaches for the treatment of autoimmune diseases, including insulin-dependent diabetes mellitus, rheumatoid arthritis, and multiple sclerosis. He has also developed state-of-the-art technologies of genomics, proteomics, and metabolomics to integrate approaches to diagnosis, prognosis, and therapy of these diseases.
2014 - Herzenberg Lectureship Award
Lewis Lanier, Ph.D (on the left) obtained his B.S. in Biology from Virginia Tech and Ph.D. in Microbiology and Immunology from the University of North Carolina – Chapel Hill. After postdoctoral studies at the Lineberg Cancer Center at the UNC – Chapel Hill and then as a Damon Runyon – Walter Winchell Cancer Research Fellow at the University of New Mexico, he joined the Research & Development Department at the Becton Dickinson Monoclonal Center in Mountain View, CA. In 1990, he joined the DNAX Research Institute of Molecular and Cellular Biology in Palo Alto, California, where he advanced to Director of Immunobiology. In 1999, Dr. Lanier joined the faculty of UCSF School of Medicine in San Francisco. His research group studies Natural Killer (NK) cells, which recognize and eliminate cells that have become transformed or infected by viruses.
2013 - Herzenberg Lectureship Award
Brent Wood, MD, Ph.D (on the right) obtained his MD and PhD from Loma Linda University followed by a residency in Anatomic and Clinical Pathology at the University of Washington in Seattle. After a fellowship in Hematopathology at the University of Washington, Dr. Wood accepted a faculty position in the Department of Laboratory Medicine at the University of Washington where he is currently Professor and Director of the Hematopathology Laboratory. His responsibilities include extensive clinical service work and teaching Hematopathology to medical technology students, medical students, residents and fellows. Flow cytometry is an area of particular interest for Dr. Wood and he is responsible for implementing the first use of 9 and 10 color flow cytometry in the clinical laboratory and exploiting its potential for the identification of minimal residual disease in acute lymphoid and myeloid leukemia. His laboratory serves as one of two national reference laboratories for the identification of minimal residual disease in childhood acute lymphoblastic leukemia for the Children's Oncology Group and is involved in similar protocols with the Southwest Oncology Group. Dr. Wood lectures both nationally and internationally on clinical applications of flow cytometry and is President of the International Clinical Cytometry Society.
Dr. Garry Nolan recieved his undergraduate degree from Cornell Univerisity in Genetics emphasizing his research on Rhizobium Genetics, later under the direction of the Leonard and Leonore Herzenberg lab he recieved his PhD in Genetics from Stanford University on CD8 cloning; heritability of transcription states and FACS-Gal assay for in vivo measure of transcription. Dr. Nolan then completed his Postdoctoral at MIT/Rockefeller University in the Laboratory of David Baltimore focusing his studies on NF-kappa B, Bcl-3, BOSC23 transient retroviral producer systems.
Dr. Nolan now runs his own lab at Stanford University and has become a reknown scientist and expertise in studying cancer, autoimmunity, and the molecular manners in which single cells can be distinguished from normal human tissues, and their biology. His lab uses advanced Flow Cytometry analysis (FACS) of phospho proteins in single cells. They have successfully developed advanced signaling analysis approaches at single cell levels, coupled these to high throughput proteomics technologies and Bayesian mathematics to facilitate understanding of signaling pathways in normal and diseased cells.For more information on his lab and their studies visit the Nolan Lab website to learn more.